Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

NCT00942994 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Aliskiren/Amlodipine
DRUG: Aliskiren/Amlodipine and Hydrochlorothiazide (HCTZ)

Sponsor

Novartis